netFormulary Buckinghamshire Formulary NHS
Buckinghamshire Healthcare NHS Trust
Buckinghamshire CCG

Welcome to the Buckinghamshire Formulary

Useful Links

Links for all users:
BHT Intranet Users Only:


News Feed

November 18 - MHRA Drug Safety Update:  Sildenafil (Revatio and Viagra): reports of persistent pulmonary hypertension of the newborn (PPHN) following in-utero exposure in a clinical trial on intrauterine growth restriction

November 18 - MHRA Drug Safety Update:  Systemic and inhaled fluoroquinolones: small increased risk of aortic aneurysm and dissection; advice for prescribing in high-risk patients

November 18 - MHRA Drug Safety Update:  Hydrochlorothiazide: risk of non-melanoma skin cancer, particularly in long-term use

October 18 - MHRA Drug Safety Update: Transdermal fentanyl patches: life-threatening and fatal opioid toxicity from accidental exposure, particularly in children

October 18 - MHRA Drug Safety Update:  Ponatinib (Iclusig▼): reports of posterior reversible encephalopathy syndrome

October 18 - MHRA Drug Safety Update:  Ritonavir-containing products: reports of interaction with levothyroxine leading to reduced thyroxine levels

>>> more news

The Buckinghamshire Formulary is a joint venture between Buckinghamshire Healthcare NHS Trust and Buckinghamshire CCG.  

All chapters of the Formulary are ready for use:

1.  Search for a drug or condition using the search box above.
2.  Non-formulary products are shaded in pink and labelled non-formulary.
3.  Formulary products may be found in one or more chapters.  Click on the entry in the appropriate chapter.
4.  Guidelines are linked at the top of each chapter or section, or within the individual product entry
5.  Traffic light classifications are displayed as a traffic light symbol
6.  Any comments/queries please email

Other Formulary Related Information:


IV Guide




NHS Clinical Knowledge Summaries

   Visits = 126225
   Last updated: 07/12/2018 17:19:47
    Download net formulary from Apple IOS Store  Google Play net formulary